Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New Mexico State Investment Council (NMSIC) is a sovereign wealth fund and state agency responsible for managing New Mexico's permanent endowments, including the Land Grant Permanent Fund and the Severance Tax Permanent Fund. While not a biotechnology company itself, NMSIC is a significant institutional investor that provides capital to venture capital and private equity funds, some of which focus on life sciences and healthcare technology. Through its New Mexico Catalyst Fund and other in-state investment programs, the Council supports the growth of the local biotech ecosystem by investing in early-stage companies and innovation hubs. The Council's primary objective is to provide long-term financial benefits to the state's citizens and public schools through prudent investment management. It is headquartered in Santa Fe and manages a diverse portfolio of global assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Mexico State Investment Council.